SCHEMBL4155153

SCHEMBL4155153

CN(C)Cc1ccc(C2CCCN2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.44
CHRNB2 P17787 2/20 0.42
CHRNA7 P36544 2/20 0.42
CHRNA4 P43681 2/20 0.42
HRH3 Q9Y5N1 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HRH4 Q9H3N8 1/20 0.40
LTA4H P09960 1/20 0.39
CHRM2 P08172 3/20 0.39
CHRM4 P08173 2/20 0.39
CHRM5 P08912 2/20 0.39
CHRM1 P11229 2/20 0.39
CHRM3 P20309 2/20 0.39
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
MEN1 O00255 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8219698 0.81 CHRNA7 (0.45) CHRNB2CHRNA7CHRNA4L3MBTL1CHRM2
SCHEMBL6178200 0.81 MKNK1 (0.48) MKNK1CHRNB2CHRNA7CHRNA4L3MBTL1
SCHEMBL716893 0.81 MKNK1 (0.48) MKNK1CHRNB2CHRNA7CHRNA4L3MBTL1
SCHEMBL25322649 0.79 HRH3 (0.41) HRH3HRH4LTA4HALDH1A1TSHR
SCHEMBL2110852 0.77 ALDH1A1 (0.49) MKNK1CHRNB2CHRNA7CHRNA4L3MBTL1
SCHEMBL8611268 0.76 CYP2D6 (0.47) MKNK1CHRNB2CHRNA7CHRNA4L3MBTL1
SCHEMBL21806676 0.75 CHRNB2 (0.44) MKNK1CHRNB2CHRNA7CHRNA4L3MBTL1
SCHEMBL1829565 0.75 LTA4H (0.54) CHRNB2CHRNA7CHRNA4L3MBTL1LTA4H
SCHEMBL7992297 0.74 MKNK1 (0.55) MKNK1CHRNB2CHRNA7CHRNA4L3MBTL1
SCHEMBL6179719 0.74 MKNK1 (0.55) MKNK1CHRNB2CHRNA7CHRNA4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS HSP90AB1, HSP90AA1, HSP90AB2P MKNK1 1348/4885CHRNB2 4645/4885CHRNA7 4663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.